Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells.
Peptide-pulsed T2 cells are routinely used to study T-cell activation by MHC-restricted peptides derived from tumor-associated antigens (TAAs). Nevertheless, the capacity of T2 cells to present antigenic epitopes remains to be precisely quantified, primarily due to the detection limits imposed by available methods. Since naturally-processed TAA-derived epitopes have been shown to be displayed at levels as low as 10-150 copies per cell, highly sensitive detection and quantification techniques are essential to assess the natural degree of T-cell sensitivity. Here, we report the use of soluble, high-affinity T-cell receptors (TCRs) coupled with single-molecule fluorescence microscopy to quantify three reported TAA-derived epitopes on peptide-pulsed T2 cells, dissecting the relationship between concentration of exogenous peptide, number of epitopes presented, and activation of epitope-specific T cells. Our findings indicate that peptide concentrations in the low nanomolar range are required for T2 cells to present TAAs in extents that are comparable to those of malignant cells.
Immunocore Ltd; Oxon, UK.
Giovanna
G
Bossi
Adaptimmune Ltd; Oxon, UK.
Andrew B
AB
Gerry
Immunocore Ltd; Oxon, UK.
Samantha J
SJ
Paston
Immunocore Ltd; Oxon, UK.
Deborah H
DH
Sutton
Immunocore Ltd; Oxon, UK.
Namir J
NJ
Hassan
Immunocore Ltd; Oxon, UK ; Adaptimmune Ltd; Oxon, UK.
Bent K
BK
Jakobsen
T-cell activation; T-cell receptor; T2 cells; antigen presentation; fluorescence microscopy; monoclonal TCR; tumor-associated antigens